Many drugs are rushed onto the market even though the drug’s manufacturers may not have properly evaluated and assessed the risks and the potential side effects. Onglyza is one such drug that may have been rushed onto the market before the risks were known.
Studies found a possible link between the use of Onglyza and heart failure and pancreatic cancer. Onglyza is a medication that is prescribed for the treatment of type two diabetes. It helps to lower blood sugar by prompting the pancreas to release insulin, as well as limiting the production of glucose by the liver.
Although there are many other diabetes medications on the market, Onglyza does not cause weight gain or weight retention. In 2014, the FDA issued a safety alert for the drug and began an investigation to determine if the drug had serious side effects or was linked to life-threatening conditions. The FDA found that there did appear to be a link between Onglyza and heart problems, and Onglyza and pancreatic tumors and cancer.
If you have taken Onglyza and experienced very serious side effects as a result, you should consider pursuing a case under product liability law. Under product liability law, anyone injured by a defective product (such as a dangerous prescription drug) has the right to hold the manufacturer liable for any injuries that resulted from using the product as directed.If you have been injured by a defective drug, call the defective prescription drug attorneys at Kennedy Hodges at 855-947-0707. We can help. Call us today to learn more or to schedule a free consultation on your case. You can also visit us on Facebook to learn more.